Carillion plc’s contract wins could be worth much more than £300m

Contract wins could help Carillion plc (LON:CLLN) secure funding – and therefore its future.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in embattled support services firm Carillion (LSE: CLLN) barely paused for breath yesterday after the company reported two contract wins. The long-term deals were awarded by the Defense Infrastructure Organisation and are expected to contribute £158m to core revenue over the next five years. If Carillion can take advantage of all periphery opportunities, it believes this figure could double.  

The company will provide ‘soft services’ including catering, retail and leisure at 233 military establishments in the North of England, Scotland and Northern Ireland over the next five years. Contract wins are the lifeblood of services firms but the total revenue potential of these deals pale in comparison to the £845m provision for underperforming contracts, the £700m net debt pile and the £805m pension deficit that currently dog this one’s financial performance. 

To discount these wins as irrelevant would perhaps be a little hasty however, as I believe they could help build the momentum Carillion needs to survive.

A Bearish Bounty

Carillion is the most shorted stock on the exchange and has been for a year and a half. The shares have already fallen 75% this year but, according to the FT, 16 funds are still shorting it today. The bear case rested on the company’s revenue recognition policy. 

Revenues are calculated through a process of estimates and can, therefore, differ heavily from cashflows over the course of a five-year contract. Many costs can fluctuate in such a time period, including labour, machine rental, raw materials and more.

Delays are a cost of doing business too, but are hard to quantify ahead of time. For example, the company’s Public Private Partnership deals, originally considered safe sources of cashflow, have encountered significant amounts of asbestos at great cost. 

Depending on how aggressive forecasts are, this can lead to sudden profit warnings as we’ve seen at Carillion. On top of that, it is hard to form a competitive advantage, aside from scale, in the services industry. Margins are often paper thin and it often doesn’t take much to shunt a company from a profit to a loss.

Contract critical

That said, recent business wins at Carillion are promising. Because these contracts can drag on for years, customers are acutely aware of their service provider’s finances. You wouldn’t want the firm going bankrupt halfway through a contract now, would you? 

Carillion’s balance sheet is weak. Most tangible assets are receivables that – if certain press articles are to be believed – may not be received in full. However, a £500m fundraising should be enough to see it fighting fit again, but that’s a huge ask given the £260m market cap.

Potential customers might avoid it due to its financial frailty. In turn, investors may be unwilling to provide the necessary injection of capital given the poor business outlook. The recent contract wins help reverse this vicious cycle and in doing so increase the chance of a favourable fundraiser. 

But in its current state, I still consider Carillion unworthy of an investment. Even if it wasn’t mired in uncertainty I’d be put off by the industry itself. Contracts often go to the lowest bidder and it seems inevitable that working on long-term, low-margin contracts will go wrong for all but the most experienced of management teams. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zach Coffell has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »